UK markets closed

Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
32.10+0.50 (+1.58%)
At close: 9:48AM BST
Currency in EUR

Valuation measures

Market cap (intra-day) 51.91B
Enterprise value 31.79B
Trailing P/E 33.65
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)4.83
Price/book (mrq)5.05
Enterprise value/revenue 34.53
Enterprise value/EBITDA 624.40

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3N/A
S&P500 52-week change 314.38%
52-week high 332.10
52-week low 332.10
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 549.31M
Float 20.01M
% held by insiders 168.17%
% held by institutions 116.72%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.17
Trailing annual dividend yield 30.55%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 13.35%
Operating margin (ttm)15.05%

Management effectiveness

Return on assets (ttm)7.48%
Return on equity (ttm)16.18%

Income statement

Revenue (ttm)394.91M
Revenue per share (ttm)7.15
Quarterly revenue growth (yoy)-5.50%
Gross profit (ttm)211.43M
EBITDA 73.36M
Net income avi to common (ttm)52.7M
Diluted EPS (ttm)0.95
Quarterly earnings growth (yoy)69.20%

Balance sheet

Total cash (mrq)35.51M
Total cash per share (mrq)0.64
Total debt (mrq)75.36M
Total debt/equity (mrq)21.39
Current ratio (mrq)3.15
Book value per share (mrq)6.36

Cash flow statement

Operating cash flow (ttm)-26.66M
Levered free cash flow (ttm)-70.6M